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Among the different infective stages thatTrypanosoma cruzi employs to invade cells, extra-
cellular amastigotes (EAs) have recently gained attention by our group.This is true primarily
because these amastigotes are able to infect cultured cells and animals, establishing a
sustainable infective cycle. EAs are thus an excellent means of adaptation and survival for
T. cruzi, whose different infective stages each utilize unique mechanisms for attachment
and penetration. Here we discuss some features of host cell invasion by EAs and the
associated host cell signaling events that occur as part of the process.
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INTRODUCTION
The parasite Trypanosoma cruzi employs a variety of distinct
strategies to facilitate invasion of mammalian cells. For instance,
multiple infective stages [e.g., bloodstream trypomastigotes,meta-
cyclic trypomastigotes, and extracellular amastigotes (EAs)], vary-
ing strains and isolates, as well as differing infectivities have been
widely acknowledged as signiﬁcant obstacles to effective treatment.
The multitude of invasive strategies employed by T. cruzi repre-
sents an important survival advantage for the organism and allows
for the remarkably wide range of mammalian hosts affected by
this parasite. More speciﬁcally, T. cruzi infects over 100 species
from several orders and develops in vivo within a variety of cellu-
lar niches, including macrophages, muscle tissue, epithelial cells,
ﬁbroblasts, and nerve cells. The ability of T. cruzi to invade, persist
and adapt in both invertebrate and vertebrate hosts is multifacto-
rial, and depends on both the parasite and host ﬁtness. The cellular
communication between parasite and its host is constant and has
evolved to be relatively benign, as killing the host would not be
advantageous to the parasite.
Extracellular amastigotes are either prematurely released from
infected cells or generated by the extracellular differentiation of
released trypomastigotes (reviewed in Lima et al., 2010). During
the acute phase of T. cruzi infection within mice, EAs represent
10% of circulating parasite forms and are capable of sustain-
ing an infective cycle in the mammalian host and cells (Andrews
et al., 1987).
Among the EA stage, T. cruzi I strains (such as the G and
Tulahuén strains) are more infective than T. cruzi II and VI strains
(such as the Y and CL strains; Fernandes and Mortara, 2004;
Mortara et al., 2005). In contrast to trypomastigotes, the recruit-
ment of actin is central to the uptake of EA forms in mammalian
host cells (Figure 1), including HeLa cells, the model cell type
used in our studies (Mortara, 1991; Procópio et al., 1998; Mortara
et al., 2005).
Herewe aim tohighlight aspects of host cell invasionbyEAs and
introduce novel ﬁndings including the involvement of molecules
from both host cell and the parasite that trigger host cell signaling
events.
MAMMALIAN CELL INVASION BY EXTRACELLULAR
AMASTIGOTES: THE STORY BEGINS
Prior to themid 1980s, chronic infectionwithT. cruzi was assumed
to be sustained by few trypomastigotes in the bloodstream that
had escaped the immune response and invaded new cells. The fate
of amastigotes at that time was thought to be restricted to the
intracellular growth of the parasite. However, pioneering studies
(Behbehani, 1973; Nogueira and Cohn, 1976; Lanar, 1979; Abra-
hamsohn et al., 1983; McCabe et al., 1984; Carvalho and de Souza,
1986) demonstrated that amastigotes shared some physiological
characteristics with trypomastigotes, such as the ability to invade
and develop within cells in vitro and the ability to infect mice.
For instance, McCabe et al. (1984) demonstrated that amastigotes
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FIGURE 1 |Trypanosoma cruzi G strain amastigotes interact with
microvilli on the surface of HeLa cells. Parasites (colored in red) imaged by
ﬁeld emission-scanning electron microscopy, attach to HeLa cell surface
microvilli. Magniﬁcation bar = 5 μm.
isolated from the spleen of mice infected with three different
strains of T. cruzi (Y, MR, and Tulahuén) were able to infect,
survive, and replicate within professional and non-professional
(L929 cell line) phagocytes. In a different study, Carvalho and
de Souza (1986) obtained highly puriﬁed amastigotes (Y strain)
from themacrophage-like cell line J774G8. These amastigoteswere
effectively ingested by macrophages and were able to initiate intra-
cellular replication. Parasite development in vitro was measured
by means of light microscopy. Moreover, puriﬁed amastigotes
were highly infective when inoculated into mice, generating high
parasitemia and even death (McCabe et al., 1984; Carvalho and de
Souza, 1986).
Andrews et al. (1987) found that amastigotes accounted for
10% of circulating forms in the blood of mice during the
acute phase of infection. Furthermore, this amastigote form
was shown to express a speciﬁc surface glycoprotein that was
designated Ssp-4. These observations were corroborated when
Ley et al. (1988), by using transmission and scanning electron
microscopy, demonstrated that extracellular axenically derived
amastigotes (i.e., trypomastigote–amastigote differentiation in
axenic medium) were able to multiple within cells in vitro. When
injected intraperitoneally, the amastigote forms were as infective
to mice as trypomastigotes. Researchers were also able to measure
the infectivity and the multiplication rates of the parasites inside
cultured cells (Ley et al., 1988). The process of trypomastigote–
amastigote differentiation in axenic medium can be accelerated by
lowering the pH of the medium (Tomlinson et al., 1995). EAs can
also be obtained from axenic culture media speciﬁcally designed
for isolating amastigotes (Pan,1978; Rondinelli et al., 1988). Extra-
cellular (axenically derived) amastigotes resembled intracellular
amastigotes with regard to cell body and kinetoplast morphology,
and cell surface expression of Ssp-4 (Ley et al., 1988; Barros et al.,
1997; Silva et al., 1998).
In vitro, amastigotes are able to infect and complete their life
cycle within phagocytic and non-phagocytic host cells, possibly
using distinct molecular mechanisms for invasion and escape
from the parasitophorous vacuole (Pan, 1978; Carvalho and de
Souza, 1986; Ley et al., 1988; Mortara, 1991; Procópio et al.,
1998, 1999; Andreoli and Mortara, 2003; Mortara et al., 2005;
Florencio-Martínez et al., 2010; Bambino-Medeiros et al., 2011).
In vivo, EAs were intraperitoneally inoculated into groups
of ﬁve A/J mice and all mice were not only infected, but died
after 18–25 days. Two trypomastigote parasitemia peaks were
observed on days 7 and 12. Signiﬁcantly higher numbers of par-
asites were observed during the second peak in mice that were
inoculated with Y strain amastigotes (Ley et al., 1988). EAs were
also resistant to complement-mediated lysis (Carvalho and de
Souza, 1986; Iida et al., 1989; Fernandes and Mortara, 2004), a
feature thought to be required for infectivity. The general conclu-
sion from these studies was that EAs, once prematurely released
from dead cells, may persistently infect resident macrophages
by initiating an alternative subcycle and/or using an alterna-
tive pathway of invasion. It was hypothesized that these events
could be crucial for the maintenance of tissue infection and
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inﬂammation (Scharfstein and Morrot, 1999) within the mamma-
lian host.
In 1991, the mechanisms by which amastigotes invade non-
phagocytic cells began to be determined. Mortara (1991) observed
that amastigotes interact with microvilli on the dorsal surface
of HeLa cells leading to microvillus aggregation. This event can
be followed by microﬁlament clustering observable by phalloidin
staining and ﬂuorescent microscopy. By a combination of ﬂuores-
cence and scanning electron microscopy, it was observed that actin
aggregates underneath the sites of amastigote adhesion and forms
a small clump (Mortara, 1991) that was later called the actin cup-
like structure (Procópio et al., 1999). Interestingly, cytochalasin
D did not signiﬁcantly affect parasite attachment but the disrup-
tion of cellular microﬁlaments greatly inhibited amastigote entry
(Mortara, 1991; Procópio et al., 1998). In 1998, the actin cup-like
structures beneath the amastigotes at HeLa cell entry sites were
assessed by confocal microscopy (Procópio et al., 1998). In that
study, gelsolin, an actin-binding protein was overexpressed in NIH
3T3 ﬁbroblasts. This resulted in a large increase in the internaliza-
tion of amastigote forms resulting from enhanced microﬁlament
rearrangement. Components of the HeLa cytoskeleton, integrins,
and extracellular matrix, such as α-actinin, ABP280, gelsolin, α5β5
integrin, laminin, and ﬁbronectin, accumulated along with actin
at the sites of EA entry (Procópio et al., 1999).
EAs MOLECULES OF ADHESION AND SECRETION: INVASION
AND SIGNALING
Adhesion is a crucial initial step for microorganisms to invade any
cell. Association of amastigotes with host macrophages was shown
to be mediated by the macrophage mannose receptor (MR) and
mannose-binding protein (MBP; Kahn et al., 1995). MR and MBP
are C-type lectins. MBP strongly and stably binds to amastigotes,
and this interaction may contribute to parasite opsonization and
cellular invasion. MBP–amastigote interaction is stage speciﬁc, can
be inhibited by mannan, and requires calcium (Kahn et al., 1996).
The amastigote ligands for MBP include SA85-1 and other related
surface glycoproteins (Kahn et al., 1996). IFN-γ down-regulates
MR expression and thus inhibits parasite invasion and replication
within macrophages. It has recently been reported that in vivo
infection by G strain (TcI) EAs is inhibited by IFN-γ production
(Rodrigues et al., 2012). Fibronectin also appears to bridge these
initial binding steps (Tulahuén strain; Noisin and Villalta, 1989;
Procópio et al., 1999). Our group has previously shown that car-
bohydrate epitopes expressed on the surface of EAs may also play a
role in parasite adhesion toHeLa cells sincemonoclonal antibodies
inhibited the process (Silva et al., 2006).
Cruz et al. (2012) demonstrated that the treatment of HeLa
cells with recombinant amastin, a surface glycoprotein abundant
in amastigotes, reduced the infectivity of EA forms. Conversely,
the ectopic T. cruzi expression of amastin accelerated differentia-
tion of amastigotes into trypomastigotes. These results positioned
amastin as a potential amastigote molecule able to modulate EA
invasion and differentiation within mammalian cells. In addi-
tion, amastin might participate in speciﬁc host cell signaling
culminating in EA invasion.
Trypanosoma cruzi EAs may also secrete proteins in order to
aid their attachment and entry into HeLa cells. Silva et al. (2009)
identiﬁed a hypothetical protein of 21 kDa with no known orthol-
ogous in other species. So-called P21 is secreted by the parasites
and enhances amastigote invasion, especially when the recom-
binant protein is added to host cells together with parasites as
part of HeLa cell invasion assays. Researchers concluded that P21
triggers unknown host cell signaling events that lead to parasite
internalization.
Moonlighting enzymes or proteinmoonlighting refers to a phe-
nomenon in which a protein can perform more than one function,
includingunexpected functions (Jeffery,2009). Manyproteins that
moonlight are enzymes involved in glycolysis, an ancient univer-
sal metabolic pathway. It has been suggested that as many as 7 of
10 proteins in glycolysis and 7 of 8 enzymes of the tricarboxylic
acid cycle exhibit moonlighting behavior. Our group has recently
characterized a moonlighting protein in T. cruzi called meval-
onate kinase (MVK), an enzyme involved in isoprenoid synthesis.
As part of the T. cruzi infection process, this moonlighting pro-
tein is involved both in parasite invasion and host cell signaling
(Ferreira et al., unpublished). There are numerous intermedi-
ates in the mevalonate biosynthetic pathway that play important
roles in the post-translational modiﬁcation of a multitude of pro-
teins involved in intracellular signaling. These intermediates in
the mevalonate biosynthetic pathway are essential regulators of
cell growth/differentiation, gene expression, protein glycosylation,
and cytoskeletal assembly.
Microarray analysis of EA mRNAs has demonstrated that MVK
displays higher expression within G (more infective) than in CL
(less infective) parasites, suggesting an important role of the MVK
pathway in EA infectivity (Ferreira et al., unpublished). We have
obtained data indicating that MVK may be a modulator in EA
invasion and could become an important target in the develop-
ment of new drugs to treat Chagas’ disease. Moreover, in T. cruzi,
MVK is secreted and likely participates in the modulation of HeLa
cell signaling leading to EA cell invasion. These observations reveal
new possibilities for the study of moonlighting protein evolution
and function within intracellular parasites.
EAs AND HOST CELL SIGNALING
The ﬁrst experiments to describe signaling events induced by EAs
in non-phagocytic cells were performed in 1998. Procópio et al.
(1998) used a protein kinase C inhibitor, staurosporine, and also
a tyrosine kinase inhibitor, genistein, to treat HeLa cells before
invasion assays with EA. Curiously, staurosporine had no effect
whereas genistein moderately inhibited the invasion of EAs in
HeLa cells. In Vero cells, genistein had no effect but staurosporine
inhibited EA invasion by 82%. The role of RhoA GTPases in host
cell invasion by EAs of both G and CL strains of T. cruzi was
subsequently studied. Rho GTPases regulate three separate sig-
nal transduction pathways, linking plasma membrane receptors
to the assembly of distinct actin ﬁlament structures. Fernandes
and Mortara (2004) used non-polarized MDCK cells transfected
with different Rho GTPase constructs (RhoA, Rac1, and Cdc42).
EA invasion was particularly high in MDCK cells overexpressing
either wild type or constitutively active Rac1. Consistently, EA
invasion was speciﬁcally reduced in the corresponding dominant
negative line, suggesting a key role for Rac1-GTPase in the inva-
sion process (Fernandes andMortara, 2004). On the other hand, in
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contrast to a number of bacterial invasion mechanisms (Mounier
et al., 2003), amastigote invasion seems to be independent
of Cdc42.
Sonicated extracts from G or CL strain of EA induced transient
enhancement in HeLa cell intracellular Ca2+ levels in a dose-
dependent manner. Inhibition of HeLa cell intracellular Ca2+
mobilization by thapsigargin or caffeine moderately reduced the
infectivity of both G and CL strains (Fernandes et al., 2006). Thus,
EAs of both strains trigger calcium signaling in HeLa cells that may
be important for the success of EA invasion. Adenylyl cyclase based
activation of HeLa cells by exposure to forskolin did not affect
infection by either strain. The activation of PI3 kinase in host cells
appears to be required for invasion by either the G or CL strain
since treatment of HeLa cells with wortmannin reduced EA infec-
tivity (Fernandes et al., 2006). It has also been described that the
use of PI3 kinase inhibitors impairs EA (Y strain) internalization
into peritoneal macrophages by 60% (Barrias et al., 2010).
We have recently observed that the treatment of non-
phagocytic cells with a Src-family tyrosine kinase (SFK) inhibitor,
in the absence of serum, reduces EA (G strain) invasion (Bahia
et al., unpublished). In addition, EA of the G strain induced time-
dependent HeLa cell phosphorylation of SFKs, whose members
include Src, Lyn, Fyn, Lck, Yes, and Hck. At this stage, however,
the precise Src members involved in this pathway have not been
identiﬁed. These results suggest that EAs may also exploit the host
cell Src pathway in order to invade cells.
EAs AND THE HOST CELL POINT OF VIEW
Host cell plasma membrane microdomains were also shown to
be involved in EA T. cruzi entry into non-phagocytic cells. Mem-
brane microdomains, also known as lipid rafts, play a unique
role in signal transduction by compartmentalizing cell receptors
and subsequently boosting downstream signaling to the effectors
molecules (Simons and Ikonen, 1997). Cholesterol, the major
component of membrane lipid rafts of Vero or HeLa cells was dis-
rupted by methyl β-cyclodextrin (MβCD) and then infected with
EAs of G (TcI) and CL (TcVI) strains (Fernandes et al., 2007).
Removal of cholesterol from both host cell lines signiﬁcantly
decreased the invasion index of EAs, indicating that host cell
cholesterol and/or membrane organization is important for the
entry process of both infective forms. After cholesterol repletion,
the invasion index of G strain EAs was almost fully recovered. Sub-
unit B of cholera toxin binds to the GM1 ganglioside, a marker for
lipid rafts, and the treatment of non-phagocytic cells with CTB
(cholera Toxin-B) also decreased EA invasion. In macrophages,
the participation of lipid rafts in the internalization of EAs has
also been described (Barrias et al., 2007).
Barrias et al. (2010) showed that dynamin, a large GTPase that
belongs to a protein superfamily with a critical role in endocytic
membrane ﬁssion events, plays a role in EA internalization into
peritoneal macrophages. Researchers treated macrophages with
dynasore, a reagent that has the ability to block the GTPase activity
of dynamin, and observed a marked inhibition in the internaliza-
tion of EAs. However, dynasore did not signiﬁcantly interfere with
parasite adhesion to host cells.
Bambino-Medeiros et al. (2011) showed that amastigote inva-
sion also involves host cell surface heparan sulfate proteoglycans,
which localize to signaling membrane microdomains such as lipid
rafts. By treating EAs of the Dm28c strain with heparin or heparan
sulfate, researchers observed inhibition of EA entry into primary
cultures of cardiomyocytes. The authors hypothesized that the
binding of amastigote heparin-binding protein could activate dif-
ferent signaling pathways, such as phosphorylation of cortactin
by Src activation that would lead to actin polymerization and
amastigote entry.
Along these lines, we are currently evaluating the role of protein
kinaseD (PKD) and cortactin in EAuptake byHeLa cells (Bonﬁm-
Melo, unpublished). PKD is a family of multidomain enzymes
(PKD1, 2, and 3). PKD lies downstream of PKCs in a novel sig-
nal transduction pathway implicated in the regulation of multiple
fundamental biological processes. At the leading edge of migrating
cells, active PKD co-localizes with F-actin, Arp2/3, and cortactin.
Cortactin has emerged as a key signaling protein in cellular pro-
cesses such as endocytosis and tumor invasion by interacting with
and/or altering the cortical actin network. PKD is an upstream
regulator of cortactin. EAs not only recruit PKD (Figure 2) and
FIGURE 2 | Extracellular amastigotes (EAs) were incubated for 1 h with
(A)Vero or (B) CHO cells transfected with a GFP tagged PKD (green) and
stained with phalloidin-TRITC (actin) and DAPI (cells nuclei). Arrows
show EA recruiting PKD at the invasion sites. Confocal microscopy followed
by Huygens Surface Rendering (www.svi.nl). Magniﬁcation bars = 4 μm (A)
and 5 μm (B).
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FIGURE 3 | Proposed model for EA signaling. EAs secrete factors such as
P21 and MVK that aid in EA uptake by cells in culture. EAs also present
speciﬁc glycoproteins (i.e., Ssp-4) important for attachment and penetration
while other EA glycoproteins (i.e., amastins-Am) may negatively modulate
amastigote invasion. From the cellular perspective, lipid rafts are essential to
parasite internalization in both macrophages and epithelial cells. Furthermore,
the mannose receptor of certain cells may recognize mannose residues
expressed by EAs which also participate in EA uptake. Upon contact, EAs
recruit PKD, actin (F-actin), and other actin-binding proteins (ABPs) such as
cortactin (Cort), gelsolin, and α-actinin. Additionally, EAs likely activate
Src-family kinase (SFK), PKC, and Rac1 signaling in host cells. The
phosphatidylinositol 3-kinases (PI3k) pathway may also be involved in EA
internalization. Cellular heparan sulfate and ﬁbronectin are also important in
the process of EA internalization (extracellular matrix components – ECMs).
Red and green arrows: negative and positive modulation of the invasion,
respectively; blue arrows: host protein activation; black arrows: recruitment. P,
phosphorylation; n, nucleus; k, kinetoplast; MVK, mevalonate kinase; MR,
mannose receptor. See text for more details.
cortactin to the invasion sites of epithelial non-phagocytic cells,
but also induce the phosphorylation of these proteins (Bonﬁm-
Melo, unpublished). These results suggest that unexpected novel
roads may also be utilized by T. cruzi to invade cells. In order to
summarize, the putative cellular molecules and signaling pathways
used by EAs are presented in Figure 3.
CONCLUDING REMARKS
Extracellular amastigotes of T. cruzi are an infective parasite
stage that mobilizes molecules and pathways distinct from those
engaged by the classical infective trypomastigote forms. This
repertoire of moleculesmay include not only previously character-
ized carbohydrate epitopes and the P21 secreted component, but
also novel components described here such as the secreted form
of MVK and the cortactin–PKD pathway.
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